Logo image of AAQ1.DE

AAP IMPLANTATE (AAQ1.DE) Stock Price, Quote, News and Overview

FRA:AAQ1 - Deutsche Boerse Ag - DE000A3H2101 - Common Stock - Currency: EUR

1.72  -0.25 (-12.69%)

AAQ1.DE Quote, Performance and Key Statistics

AAP IMPLANTATE

FRA:AAQ1 (8/8/2025, 7:00:00 PM)

1.72

-0.25 (-12.69%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High2.98
52 Week Low1.08
Market Cap23.93M
Shares13.91M
Float5.69M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-18 2025-08-18
IPO05-10 1999-05-10


AAQ1.DE short term performance overview.The bars show the price performance of AAQ1.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20

AAQ1.DE long term performance overview.The bars show the price performance of AAQ1.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40 60 80

The current stock price of AAQ1.DE is 1.72 EUR. In the past month the price decreased by -7.03%. In the past year, price increased by 59.26%.

AAP IMPLANTATE / AAQ1 Daily stock chart

AAQ1.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 27.2 199.21B
IUI1.DE INTUITIVE SURGICAL INC 58.3 144.41B
1ISRG.MI INTUITIVE SURGICAL INC 58.33 143.64B
BSX.DE BOSTON SCIENTIFIC CORP 36.54 131.38B
2M6.DE MEDTRONIC PLC 16.7 100.99B
SHL.DE SIEMENS HEALTHINEERS AG 19.51 52.37B
BOX.DE BECTON DICKINSON AND CO 13.12 46.06B
EWL.DE EDWARDS LIFESCIENCES CORP 30.13 39.06B
DC4.DE DEXCOM INC 45.99 26.33B
PHIA.AS KONINKLIJKE PHILIPS NV 15.97 22.15B
PHI1.DE KONINKLIJKE PHILIPS NV 15.92 22.08B
1STMN.MI STRAUMANN HOLDING AG-REG 37.46 17.38B

About AAQ1.DE

Company Profile

AAQ1 logo image aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin and currently employs 87 full-time employees. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.

Company Info

AAP IMPLANTATE

Lorenzweg 5

Berlin BERLIN DE

Employees: 87

AAQ1 Company Website

AAQ1 Investor Relations

Phone: 4930750190

AAP IMPLANTATE / AAQ1.DE FAQ

What is the stock price of AAP IMPLANTATE today?

The current stock price of AAQ1.DE is 1.72 EUR. The price decreased by -12.69% in the last trading session.


What is the ticker symbol for AAP IMPLANTATE stock?

The exchange symbol of AAP IMPLANTATE is AAQ1 and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is AAQ1.DE stock listed?

AAQ1.DE stock is listed on the Deutsche Boerse Ag exchange.


What is AAP IMPLANTATE worth?

AAP IMPLANTATE (AAQ1.DE) has a market capitalization of 23.93M EUR. This makes AAQ1.DE a Nano Cap stock.


How many employees does AAP IMPLANTATE have?

AAP IMPLANTATE (AAQ1.DE) currently has 87 employees.


What are the support and resistance levels for AAP IMPLANTATE (AAQ1.DE) stock?

AAP IMPLANTATE (AAQ1.DE) has a support level at 1.53 and a resistance level at 1.93. Check the full technical report for a detailed analysis of AAQ1.DE support and resistance levels.


Is AAP IMPLANTATE (AAQ1.DE) expected to grow?

The Revenue of AAP IMPLANTATE (AAQ1.DE) is expected to grow by 15.38% in the next year. Check the estimates tab for more information on the AAQ1.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy AAP IMPLANTATE (AAQ1.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AAP IMPLANTATE (AAQ1.DE) stock pay dividends?

AAQ1.DE does not pay a dividend.


When does AAP IMPLANTATE (AAQ1.DE) report earnings?

AAP IMPLANTATE (AAQ1.DE) will report earnings on 2025-08-18.


What is the Price/Earnings (PE) ratio of AAP IMPLANTATE (AAQ1.DE)?

AAP IMPLANTATE (AAQ1.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.28).


AAQ1.DE Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to AAQ1.DE. When comparing the yearly performance of all stocks, AAQ1.DE is one of the better performing stocks in the market, outperforming 92.44% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AAQ1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AAQ1.DE. AAQ1.DE may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AAQ1.DE Financial Highlights

Over the last trailing twelve months AAQ1.DE reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS increased by 54.69% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -18.8%
ROE -29.4%
Debt/Equity 0.17
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)54.69%
Revenue 1Y (TTM)6.32%

AAQ1.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 42% to AAQ1.DE. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 65% and a revenue growth 15.38% for AAQ1.DE


Ownership
Inst Owners17.2%
Ins Owners10.14%
Short Float %N/A
Short RatioN/A
Analysts
Analysts42.22
Price TargetN/A
EPS Next Y65%
Revenue Next Year15.38%